A simple drug cocktail that converts cells neighboring damaged neurons into functional new neurons could potentially be used to treat stroke, Alzheimer’s disease, and brain injuries.
A team of researchers at Penn State identified a set of four, or even three, molecules that could convert glial cells—which normally provide support and insulation for neurons—into new neurons. A paper describing the approach appears online in the journal Stem Cell Reports on February 7, 2019.
“The biggest problem for brain repair is that neurons don’t regenerate after brain damage, because they don’t divide,” said Gong Chen, professor of biology and Verne M. Willaman Chair in Life Sciences at Penn State and leader of the research team. “In contrast, glial cells, which gather around damaged brain tissue, can proliferate after brain injury. I believe turning glial cells that are the neighbors of dead neurons into new neurons is the best way to restore lost neuronal functions.”
Chen’s team previously published research describing a sequence of nine small molecules that could directly convert human glial cells into neurons, but the large number of molecules and the specific sequence required for reprogramming the glial cells complicated the transition to a clinical treatment. In the current study, the team tested various numbers and combinations of molecules to identify a streamlined approach to the reprogramming of astrocytes, a type of glial cells, into neurons.
“We identified the most efficient chemical formula among the hundreds of drug combinations that we tested,” said Jiu-Chao Yin, a graduate student in biology at Pen State who identified the ideal combination of small molecules. “By using four molecules that modulate four critical signaling pathways in human astrocytes, we can efficiently turn human astrocytes—as many as 70 percent—into functional neurons.”
The resulting chemically converted neurons can survive more than seven months in a culture dish in the lab. They form robust neural networks and send chemical and electrical signals to each other, as normal neurons do inside the brain.
Using three of the small molecules instead of four also results in the conversion of astrocytes into neurons, but the conversion rate drops by about 20 percent. The team also tried using only one of the molecules, but this approach did not induce conversion.
Chen and his team had previously developed a gene therapy technology to convert astrocytes into functional neurons, but due to the excessive cost of gene therapy—which can cost a patient half a million dollars or more—the team has been pursuing more economical approaches to convert glial cells into neurons. The delivery system for gene therapies is also more complex, requiring the injection of viral particles into the human body, whereas the small molecules in the new method can be chemically synthesized and packaged into a pill.
“The most significant advantage of the new approach is that a pill containing small molecules could be distributed widely in the world, even reaching rural areas without advanced hospital systems,” said Chen. “My ultimate dream is to develop a simple drug delivery system, like a pill, that can help stroke and Alzheimer’s patients around the world to regenerate new neurons and restore their lost learning and memory capabilities.”
The researchers acknowledge that many technical issues still need to be resolved before a drug using small molecules could be created, including the specifics of drug packaging and delivery. They also plan to investigate potential side effects of this approach in future studies in order to develop the safest drug pills. Nonetheless, the research team is confident that this combination of molecules has promising implications for future drug therapies to treat individuals with neurological disorders.
“Our years of effort in discovering this simplified drug formula take us one step closer to reaching our dream,” said Chen.
The Latest on: Small molecules
via Google News
The Latest on: Small molecules
- Vasomune Therapeutics Announces Clinical and Scientific Advisory Boardon May 11, 2020 at 5:00 am
Members of the Vasomune Clinical and Scientific Advisory Board are: David Andrews, PhD – Dr. Andrews is Director of and Senior Scientist in Biological Sciences at Sunnybrook Research Institute, ...
- Hunting for a SARS-CoV-2 biomarker with metabolomicson May 11, 2020 at 4:02 am
Alan Jarmusch and Jack Gilbert discuss the use of metabolomic technologies to identify a chemical biomarker of COVID-19 and better understand the disease.
- Completing density functional theory by machine learning hidden messages from moleculeson May 5, 2020 at 2:25 am
Kohn–Sham density functional theory (DFT) is the basis of modern computational approaches to electronic structures. Their accuracy heavily relies on the exchange-correlation energy functional, which ...
- Hybrid image sensor of small molecule organic photodiode on CMOS – Integration and characterizationon May 5, 2020 at 2:23 am
Small molecules are well equipped for the fabrication of multilayer stacked OPDs where films can be thermally deposited on top of one another without affecting the underneath layer. This is vital as ...
- New technology enables visualization of small structures inside whole cells and tissueson May 4, 2020 at 2:05 pm
Since Robert Hooke's first description of a cell in Micrographia 350 years ago, microscopy has played an important role in understanding the rules of life.
- Laser-cooled YbOH molecules could aid the hunt for new physicson May 4, 2020 at 9:51 am
Producing a cold beam of these complex polyatomic molecules may lead to more precise searches for an electron electric dipole moment, say researchers ...
- Small-molecule defenseon April 30, 2020 at 5:30 pm
Small-peptide defense molecules are produced by most organisms to fend off invasion by bacteria. The antimicrobial peptides that we know about so far show substantial diversity, synergism, and ...
- More evidence coronavirus may cause deadly blood clots: Irish doctors find infection can cause 'hundreds of small blockages' in the lungs - and warn they 'undoubtedly' lead to ...on April 30, 2020 at 7:12 am
Doctors looked at 83 severe COVID-19 patients at St James's Hospital in Dublin. They found tiny blood clots in the lungs which can lead to low oxygen levels.
- DiscoveryBioMed and Monell Chemical Senses Center Awarded $1.68 Million Small Business Grant to Profile Bitter Taste Blockerson April 29, 2020 at 7:16 am
DiscoveryBioMed, Inc. (DBM) has been awarded nearly $1.7 million over the next two years by the National Institutes of Health’s Small Business Technol ...
- 4-billion-year-old nitrogen-containing organic molecules discovered in Martian meteoriteson April 29, 2020 at 6:43 am
A research team including research scientist Atsuko Kobayashi from the Earth-Life Science Institute (ELSI) at Tokyo Institute of Technology, Japan, and research scientist Mizuho Koike from the ...
via Bing News